🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT06902935
Starting soon Observational

Establishment and Clinical Application of Breast Cancer Risk Prediction Model Based on Traditional Chinese Medicine Four Diagnostic Instruments and Ultrasound

NCT06902935 · tracked via the Priya Life Science China tracker
Sponsor
Taizhou Hospital
Phase
Observational
Started
2025-04-26
Last updated
2025-03-30

Condition(s) studied

Breast Cancer Screening

Investigational drug(s) / intervention(s)

Diagnosis of Breast Cancer by Traditional Chinese Medicine Four ExaminationsUltrasound diagnosis of breast cancer

Diagnosis of Breast Cancer by Traditional Chinese Medicine Four Examinations: The Daosheng TCM Four-Diagnostic Instrument (DS01-A) comprehensively collects patients' TCM four-diagnostic information, covering tongue (e.g., overall color, coating color/thickness/greasiness, tooth marks, etc.), pulse (e.g., position, force, rhythm, etc.), face (e.g., overall color, luster, lip color/dryness, etc.) and constitution scores (quantifying 9 constitutions via the TCM Constitution Classification Table).

Ultrasound diagnosis of breast cancer: Professional ultrasound physicians use B - ultrasound equipment of the same model to accurately collect detailed parameters of breast masses according to a standardized process. These parameters include shape (oval, round, irregular), orientation (parallel, non - parallel), margin (smooth, non - smooth, with non - smooth including blurred, angular, microlobulated, spiculated, etc.), echo pattern (anechoic, hyperechoic, complex cystic - solid echo, hypoechoic, isoechoic, heterogeneous echo), posterior echo characteristics (no change, enhancement, shadowing, mixed), calcification (microcalcification and coarse calcification within the mass, calcification outside the mass, intraductal), and vascular supply (no blood supply, internal blood supply, marginal blood supply), etc.

Study summary

Construct a breast cancer risk prediction model based on traditional Chinese medicine four diagnostic instruments and B-ultrasound images. Ensure that the key evaluation indicators of the model reach a high level through clinical verification, so as to contribute to accurate clinical diagnosis and treatment decision-making.

Eligibility

Sex
FEMALE
Min age
30 Years
Max age
75 Years
Healthy volunteers
No
Inclusion Criteria: 1. Female patients aged between 30 and 75. 2. Patients who have a mass detected by US examination, need to undergo surgery or needle biopsy, and obtain a definite pathological result. 3. Patients who have obtained complete identification results of tongue, pulse, face, and constitution through the traditional Chinese medicine four diagnostic instruments. Exclusion Criteria: \- 1. Patients with severe heart, liver, or kidney insufficiency, or other serious systemic diseases. 2\. Patients with a history of other malignant tumors. 3. Cases with poor - quality B - ultrasound images. 4. Cases with an unclear pathological diagnosis. 5. Patients with obvious lesions on the face, in the oral cavity, or on the tongue that may affect the measurement results.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Taizhou Central Hospital (Affiliated Hospital of Taizhou University) Taizhou Zhejiang

More Taizhou Hospital trials in China

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06902935 on ClinicalTrials.gov ↗ ← All trials in China